RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCOPUS

      2019 개정 대한간학회 간경변증 진료 가이드라인 소개: 정맥류, 간성뇌증 및 관련 합병증 = Brief Review of the Revised Korean Association for the Study of the Liver Clinical Practice Guidelines for Liver Cirrhosis: Varices, Hepatic Encephalopathy and Related Complications

      한글로보기

      https://www.riss.kr/link?id=A106444979

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Liver cirrhosis patients are suffering from many complications, which are directly related to a poor prognosis. Although there have been many recent advances in diagnosis and treatment for varix and hepatic encephalopathy in cirrhotic patients, the st...

      Liver cirrhosis patients are suffering from many complications, which are directly related to a poor prognosis. Although there have been many recent advances in diagnosis and treatment for varix and hepatic encephalopathy in cirrhotic patients, the standard practice for these conditions should consider the different medical resources and etiology of these liver diseases among various countries. The Korean Association for the Study of the Liver published in 2005 a clinical practice guideline for the treatment of cirrhosis complications, and this year, they revised the guideline for treating gastroesophageal varices and hepatic encephalopathy. This review summarizes the revised practice guideline and emphasizes the updated recommendation. (Korean J Gastroenterol 2019;74:274-280)

      더보기

      참고문헌 (Reference)

      1 Gwon DI, "Vascular plug-assisted retrograde transvenous obliteration for the treatment of gastric varices and hepatic encephalopathy: a prospective multicenter study" 26 : 1589-1595, 2015

      2 Yoon EL, "Validation of the Korean Stroop test in diagnosis of minimal hepatic encephalopathy" 9 : 8027-, 2019

      3 정재윤, "Validation of a Paper and Pencil Test Battery for the Diagnosis of Minimal Hepatic Encephalopathy in Korea" 대한의학회 32 (32): 1484-1490, 2017

      4 Bajaj JS, "The multi-dimensional burden of cirrhosis and hepatic encephalopathy on patients and caregivers" 106 : 1646-1653, 2011

      5 Kimer N, "Systematic review with meta-analysis : the effects of rifaximin in hepatic encephalopathy" 40 : 123-132, 2014

      6 Azoulay D, "Salvage transjugular intrahepatic portosystemic shunt for uncontrolled variceal bleeding in patients with decompensated cirrhosis" 35 : 590-597, 2001

      7 Tandon P, "Risk of bacterial infection in patients with cirrhosis and acute variceal hemorrhage, based on Child-Pugh class, and effects of antibiotics" 13 : 1189-1196, 2015

      8 Sidhu SS, "Rifaximin vs. lactulose in treatment of minimal hepatic encephalopathy" 36 : 378-385, 2016

      9 Bass NM, "Rifaximin treatment in hepatic encephalopathy" 362 : 1071-1081, 2010

      10 Bajaj JS, "Review article : the design of clinical trials in hepatic encephalopathy--an International Society for Hepatic Encephalopathy and Nitrogen Metabolism(ISHEN)consensus statement" 33 : 739-747, 2011

      1 Gwon DI, "Vascular plug-assisted retrograde transvenous obliteration for the treatment of gastric varices and hepatic encephalopathy: a prospective multicenter study" 26 : 1589-1595, 2015

      2 Yoon EL, "Validation of the Korean Stroop test in diagnosis of minimal hepatic encephalopathy" 9 : 8027-, 2019

      3 정재윤, "Validation of a Paper and Pencil Test Battery for the Diagnosis of Minimal Hepatic Encephalopathy in Korea" 대한의학회 32 (32): 1484-1490, 2017

      4 Bajaj JS, "The multi-dimensional burden of cirrhosis and hepatic encephalopathy on patients and caregivers" 106 : 1646-1653, 2011

      5 Kimer N, "Systematic review with meta-analysis : the effects of rifaximin in hepatic encephalopathy" 40 : 123-132, 2014

      6 Azoulay D, "Salvage transjugular intrahepatic portosystemic shunt for uncontrolled variceal bleeding in patients with decompensated cirrhosis" 35 : 590-597, 2001

      7 Tandon P, "Risk of bacterial infection in patients with cirrhosis and acute variceal hemorrhage, based on Child-Pugh class, and effects of antibiotics" 13 : 1189-1196, 2015

      8 Sidhu SS, "Rifaximin vs. lactulose in treatment of minimal hepatic encephalopathy" 36 : 378-385, 2016

      9 Bass NM, "Rifaximin treatment in hepatic encephalopathy" 362 : 1071-1081, 2010

      10 Bajaj JS, "Review article : the design of clinical trials in hepatic encephalopathy--an International Society for Hepatic Encephalopathy and Nitrogen Metabolism(ISHEN)consensus statement" 33 : 739-747, 2011

      11 Tapper EB, "Refining the ammonia hypothesis : a physiology-driven approach to the treatment of hepatic encephalopathy" 90 : 646-658, 2015

      12 Bonilha DQ, "Propranolol associated with endoscopic band ligation reduces recurrence of esophageal varices for primary prophylaxis of variceal bleeding : a randomized-controlled trial" 27 : 84-90, 2015

      13 Mishra SR, "Primary prophylaxis of gastric variceal bleeding comparing cyanoacrylate injection and beta-blockers : a randomized controlled trial" 54 : 1161-1167, 2011

      14 Qi XS, "Nonselective beta-blockers in cirrhotic patients with no or small varices : a meta-analysis" 21 : 3100-3108, 2015

      15 Als-Nielsen B, "Non-absorbable disaccharides for hepatic encephalopathy : systematic review of randomised trials" 328 : 1046-, 2004

      16 Merli M, "Incidence and natural history of small esophageal varices in cirrhotic patients" 38 : 266-272, 2003

      17 Guyatt GH, "GRADE : an emerging consensus on rating quality of evidence and strength of recommendations" 336 : 924-926, 2008

      18 de Franchis R, "Expanding consensus in portal hypertension: report of the Baveno VI consensus workshop:stratifying risk and individualizing care for portal hypertension" 63 : 743-752, 2015

      19 Procaccini NJ, "Endoscopic cyanoacrylate versus transjugular intrahepatic portosystemic shunt for gastric variceal bleeding: a single-center U.S. analysis" 70 : 881-887, 2009

      20 Mishra SR, "Endoscopic cyanoacrylate injection versus beta-blocker for secondary prophylaxis of gastric variceal bleed : a randomised controlled trial" 59 : 729-735, 2010

      21 Hung HH, "Efficacy of non-selective β-blockers as adjunct to endoscopic prophylactic treatment for gastric variceal bleeding : a randomized controlled trial" 56 : 1025-1032, 2012

      22 Sarin SK, "Early primary prophylaxis with beta-blockers does not prevent the growth of small esophageal varices in cirrhosis : a randomized controlled trial" 7 : 248-256, 2013

      23 European Association for the Study of the Liver, "EASL clinical practice guidelines on nutrition in chronic liver disease" 70 : 172-193, 2019

      24 Puente A, "Drugs plus ligation to prevent rebleeding in cirrhosis : an updated systematic review" 34 : 823-833, 2014

      25 Qiao W, "Cyanoacrylate injection versus band ligation in the endoscopic management of acute gastric variceal bleeding: meta-analysis of randomized, controlled studies based on the PRISMA statement" 94 : e1725-, 2015

      26 Luo M, "Clinical efficacy and safety of lactulose for minimal hepatic encephalopathy : a meta-analysis" 23 : 1250-1257, 2011

      27 Park SW, "Changes in cardiac varices and their clinical significance after eradication of esophageal varices by band ligation" 2016 : 2198163-, 2016

      28 "Cause-of-death statistics in 2018 in the Republic of Korea" Statistics Korea

      29 Bhardwaj A, "Carvedilol delays the progression of small oesophageal varices in patients with cirrhosis : a randomised placebo-controlled trial" 66 : 1838-1843, 2017

      30 Lockwood AH, "Blood ammonia levels and hepatic encephalopathy" 19 : 345-349, 2004

      31 Groszmann RJ, "Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis" 353 : 2254-2261, 2005

      32 Garrido M, "An educational tool for the prophylaxis of hepatic encephalopathy" 4 : e000161-, 2017

      33 Sharma BC, "A randomized, double-blind, controlled trial comparing rifaximin plus lactulose with lactulose alone in treatment of overt hepatic encephalopathy" 108 : 1458-1463, 2013

      34 Korean Association for the Study of the Liver, "2019 Korean Association for the Study of the Liver clinical practice guidelines for liver cirrhosis: varices, hepatic encephalopathy and related complications" Jin Publishing Co 2019

      더보기

      동일학술지(권/호) 다른 논문

      동일학술지 더보기

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2022 평가예정 재인증평가 신청대상 (재인증)
      2019-01-01 평가 등재학술지 유지 (계속평가) KCI등재
      2011-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2009-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2007-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2005-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2002-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      1999-07-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.18 0.18 0.18
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.21 0.2 0.315 0.03
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼